MAPT and Pick disease: In addition, the in vivo reactivity of [18F]PM-PBB3 with FTLD Tau inclusion was strongly supported by neuropathological examinations of brains derived from Pick′s disease, PSP and corticobasal-degeneration patients who underwent Tau PET imaging [128].